68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor

Overview

Journal Clin Nucl Med

Specialty Nuclear Medicine

Date 2020 Sep 24

PMID 32969904

Citations 15

Authors

Bingxin Gu

Zhiguo Luo

Xinhong He

Jian Wang

Shaoli Song

Affiliations

Soon will be listed here.

Abstract

Extrapulmonary tuberculosis (TB) is difficult to diagnose. Here, we report a case of extrapulmonary TB in a 68-year-old woman presented with mental fatigue, poor appetite, and weight loss. F-FDG PET/CT revealed elevated F-FDG uptake in the left inferior cervical, left supraclavicular, mediastinal, and splenic hilum lymph nodes and spleen, which were suspected of malignant tumor. To further differentiate benign and malignant diseases, Ga-FAPI PET/CT was performed. Ga-FAPI PET/CT also showed intense Ga-FAPI uptake in the previously mentioned FDG-avid lesions. However, biopsy of the left supraclavicular lymph node demonstrated the presence of TB.

Citing Articles

FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management.

Guo W, Xu W, Meng T, Fan C, Fu H, Pang Y Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39883140 DOI: 10.1007/s00259-025-07108-2.

Epithelioid granuloma mimicking lung cancer showed intense uptake on [F]FAPI-74 PET.

Watabe T, David I, Kimura T, Hiroshima T, Tatsumi M, Naka S Eur J Nucl Med Mol Imaging. 2023; 51(3):930-931.

PMID: 37891330 PMC: 10796733. DOI: 10.1007/s00259-023-06478-9.

FAPI PET/CT Imaging-An Updated Review.

Chandekar K, Prashanth A, Vinjamuri S, Kumar R Diagnostics (Basel). 2023; 13(12).

PMID: 37370912 PMC: 10297281. DOI: 10.3390/diagnostics13122018.

What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.

Evangelista L, Filippi L, Schillaci O Ann Nucl Med. 2023; 37(8):442-450.

PMID: 37341971 PMC: 10345025. DOI: 10.1007/s12149-023-01852-x.

FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use.

Kirienko M, Centonze G, Sabella G, Sollai M, Sollini M, Lan X Eur J Nucl Med Mol Imaging. 2023; 50(10):3042-3049.

PMID: 37140668 DOI: 10.1007/s00259-023-06246-9.

References

Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J . Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med. 2018; 59(9):1415-1422. DOI: 10.2967/jnumed.118.210443. View

Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jager D . A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med. 2018; 59(9):1423-1429. PMC: 6126438. DOI: 10.2967/jnumed.118.210435. View

Loktev A, Lindner T, Burger E, Altmann A, Giesel F, Kratochwil C . Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. J Nucl Med. 2019; 60(10):1421-1429. PMC: 6785792. DOI: 10.2967/jnumed.118.224469. View

Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R . Radiation Dosimetry and Biodistribution of Ga-FAPI-46 PET Imaging in Cancer Patients. J Nucl Med. 2019; 61(8):1171-1177. PMC: 7413240. DOI: 10.2967/jnumed.119.236786. View

Pan Q, Luo Y, Zhang W . Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT. Clin Nucl Med. 2020; 45(4):312-313. DOI: 10.1097/RLU.0000000000002919. View